{"transactions":[{"id":427997,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT","position":1,"cik":"0000001800","reported_name":"ABBOTT LABORATORIES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16218,"kind":"person","name":"Abbott Products","position":2,"cik":"0001650190","reported_name":"Abbott Products","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16219,"kind":"organization","name":"Abbott Investments Luxembourg S.A R.L.","position":3,"cik":"0001635614","reported_name":"Abbott Investments Luxembourg S.A R.L.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares, nominal value Euro 0.01 per share","published_at":"2017-03-24T11:34:04.000Z","date":"2017-03-23","kind":"sale","acquired":false,"shares":44000000,"price":41.6,"value":1830400000.0,"ownership":{"direct":false,"nature":"By Subsidiaries"},"balance_after":25750000,"source":{"system":"sec-edgar","filing":"0001104659-17-019006","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917019006/a4.xml","form_type":"4"}},{"id":452100,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT","position":1,"cik":"0000001800","reported_name":"ABBOTT LABORATORIES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16406,"kind":"organization","name":"Abbott Established Products Holdings Gibraltar Ltd","position":2,"cik":"0001635611","reported_name":"Abbott Established Products Holdings Gibraltar Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16219,"kind":"organization","name":"Abbott Investments Luxembourg S.A R.L.","position":3,"cik":"0001635614","reported_name":"Abbott Investments Luxembourg S.A R.L.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Call Option (Obligation to Sell)","published_at":"2015-04-09T20:44:36.000Z","date":"2015-04-07","kind":"other","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Subsidiaries"},"balance_after":0,"derivative":{"exercise_price":56.8912,"exercise_date":"2015-03-31","expiration_date":"2015-04-30","underlying":"Ordinary Shares","underlying_shares":5250000},"source":{"system":"sec-edgar","filing":"0001104659-15-026765","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465915026765/a4.xml","form_type":"4"}},{"id":452099,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT","position":1,"cik":"0000001800","reported_name":"ABBOTT LABORATORIES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16406,"kind":"organization","name":"Abbott Established Products Holdings Gibraltar Ltd","position":2,"cik":"0001635611","reported_name":"Abbott Established Products Holdings Gibraltar Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16219,"kind":"organization","name":"Abbott Investments Luxembourg S.A R.L.","position":3,"cik":"0001635614","reported_name":"Abbott Investments Luxembourg S.A R.L.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares, nominal value Euro 0.01 per share","published_at":"2015-04-09T20:44:36.000Z","date":"2015-04-07","kind":"other","acquired":false,"shares":5250000,"price":56.8912,"value":298678800.0,"ownership":{"direct":false,"nature":"By Subsidiaries"},"balance_after":69750000,"source":{"system":"sec-edgar","filing":"0001104659-15-026765","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465915026765/a4.xml","form_type":"4"}},{"id":452427,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT","position":1,"cik":"0000001800","reported_name":"ABBOTT LABORATORIES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16412,"kind":"organization","name":"Laboratoires Fournier S.A.S.","position":2,"cik":"0001635767","reported_name":"Laboratoires Fournier S.A.S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16406,"kind":"organization","name":"Abbott Established Products Holdings Gibraltar Ltd","position":3,"cik":"0001635611","reported_name":"Abbott Established Products Holdings Gibraltar Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16219,"kind":"organization","name":"Abbott Investments Luxembourg S.A R.L.","position":4,"cik":"0001635614","reported_name":"Abbott Investments Luxembourg S.A R.L.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Call Option (Obligation to Sell)","published_at":"2015-04-02T20:34:26.000Z","date":"2015-03-31","kind":"other","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Subsidiaries"},"balance_after":1,"derivative":{"exercise_price":56.8912,"exercise_date":"2015-03-31","expiration_date":"2015-04-30","underlying":"Ordinary Shares","underlying_shares":5250000},"source":{"system":"sec-edgar","filing":"0001104659-15-025547","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465915025547/a4.xml","form_type":"4"}},{"id":452426,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT","position":1,"cik":"0000001800","reported_name":"ABBOTT LABORATORIES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16412,"kind":"organization","name":"Laboratoires Fournier S.A.S.","position":2,"cik":"0001635767","reported_name":"Laboratoires Fournier S.A.S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16406,"kind":"organization","name":"Abbott Established Products Holdings Gibraltar Ltd","position":3,"cik":"0001635611","reported_name":"Abbott Established Products Holdings Gibraltar Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16219,"kind":"organization","name":"Abbott Investments Luxembourg S.A R.L.","position":4,"cik":"0001635614","reported_name":"Abbott Investments Luxembourg S.A R.L.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares, nominal value euro 0.01 per share","published_at":"2015-04-02T20:34:26.000Z","date":"2015-03-31","kind":"other","acquired":false,"shares":35000000,"price":56.8912,"value":1991192000.0,"ownership":{"direct":false,"nature":"By Subsidiaries"},"balance_after":75000000,"source":{"system":"sec-edgar","filing":"0001104659-15-025547","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465915025547/a4.xml","form_type":"4"}}]}